Oppenheimer Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-36,326
| Closed | -$1.13M | – | 1135 |
|
|
2022
Q2 | $1.13M | Sell |
36,326
-1,238
| -3% | -$38.4K | 0.02% | 638 |
|
|
2022
Q1 | $1.54M | Buy |
37,564
+4,226
| +13% | +$173K | 0.02% | 611 |
|
|
2021
Q4 | $1.45M | Sell |
33,338
-3,494
| -9% | -$152K | 0.02% | 655 |
|
|
2021
Q3 | $1.84M | Buy |
36,832
+168
| +0.5% | +$8.41K | 0.03% | 563 |
|
|
2021
Q2 | $2.31M | Buy |
36,664
+9,891
| +37% | +$623K | 0.03% | 482 |
|
|
2021
Q1 | $2.49M | Buy |
26,773
+2,237
| +9% | +$208K | 0.04% | 450 |
|
|
2020
Q4 | $2.2M | Buy |
24,536
+28
| +0.1% | +$2.51K | 0.04% | 461 |
|
|
2020
Q3 | $2.53M | Sell |
24,508
-22,506
| -48% | -$2.33M | 0.05% | 376 |
|
|
2020
Q2 | $3.72M | Buy |
47,014
+6,606
| +16% | +$522K | 0.08% | 285 |
|
|
2020
Q1 | $2.34M | Buy |
40,408
+4,646
| +13% | +$269K | 0.06% | 316 |
|
|
2019
Q4 | $1.93M | Sell |
35,762
-274
| -0.8% | -$14.8K | 0.04% | 420 |
|
|
2019
Q3 | $1.88M | Sell |
36,036
-677
| -2% | -$35.4K | 0.04% | 423 |
|
|
2019
Q2 | $1.77M | Buy |
+36,713
| New | +$1.77M | 0.04% | 440 |
|